Chronic use of pravastatin reduces insulin exocytosis and increases β-cell death in hypercholesterolemic mice
Highlights • Hypercholesterolemic mice have reduced insulin secretion. • We hypothesized that pravastatin treatment improves insulin secretion. • Pravastatin chronic treatment impaired glucose stimulated insulin secretion. • Pravastatin also decreased the expression of exocytotic SNARE proteins. • P...
Gespeichert in:
Veröffentlicht in: | Toxicology (Amsterdam) 2016-02, Vol.344, p.42-52 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 52 |
---|---|
container_issue | |
container_start_page | 42 |
container_title | Toxicology (Amsterdam) |
container_volume | 344 |
creator | Lorza-Gil, Estela Salerno, Alessandro G Wanschel, Amarylis C.B.A Vettorazzi, Jean F Ferreira, Mônica S Rentz, Thiago Catharino, Rodrigo R Oliveira, Helena C.F |
description | Highlights • Hypercholesterolemic mice have reduced insulin secretion. • We hypothesized that pravastatin treatment improves insulin secretion. • Pravastatin chronic treatment impaired glucose stimulated insulin secretion. • Pravastatin also decreased the expression of exocytotic SNARE proteins. • Pravastatin induced apoptosis signaling and death rates in pancreatic islets. |
doi_str_mv | 10.1016/j.tox.2015.12.007 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1808075342</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S0300483X15300627</els_id><sourcerecordid>1773807042</sourcerecordid><originalsourceid>FETCH-LOGICAL-c474t-bef2915995bd1e833f84429f3d8f39a57ed4e48064261560ba04b5a1f88845553</originalsourceid><addsrcrecordid>eNqNkkuO1DAQhi0EYpqBA7BBWbJJKL8SR0hIqMVLGokFILGzHKeidpOOGzsZTV-Lg3AmKvTAggWwsMou_fW7VF8x9phDxYHXz_bVHG8qAVxXXFQAzR224aZpS8mNvss2IAFKZeTnC_Yg5z0ACKnq--xC1KbRjdEbNm13KU7BF0vGIg7FMblrl2c3h6lI2C8ecxGmvIz0xpvoT3PMIRdu6intE7pMgu_fSo_jWPTo5h3li93piMnv4oh5xkThQD_QwYfs3uDGjI9u4yX79PrVx-3b8ur9m3fbl1elV42ayw4H0XLdtrrrORopB6OUaAfZm0G2TjfYK1QGaiVqrmvoHKhOOz4YY5TWWl6yp2ffY4pfF-rCHkJee3QTxiVbbsBAo6US_5bSnIQGzeV_SBtJtvDTlZ-lPsWcEw72mMLBpZPlYFd4dm8Jnl3hWS4swaOaJ7f2S3fA_nfFL1okeH4WII3uOmCy2QecPPYhoZ9tH8Nf7V_8Ue2JavBu_IInzPu4pImYWG4zFdgP6_asy8M1XWrRyB8ZcMAZ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1773807042</pqid></control><display><type>article</type><title>Chronic use of pravastatin reduces insulin exocytosis and increases β-cell death in hypercholesterolemic mice</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Lorza-Gil, Estela ; Salerno, Alessandro G ; Wanschel, Amarylis C.B.A ; Vettorazzi, Jean F ; Ferreira, Mônica S ; Rentz, Thiago ; Catharino, Rodrigo R ; Oliveira, Helena C.F</creator><creatorcontrib>Lorza-Gil, Estela ; Salerno, Alessandro G ; Wanschel, Amarylis C.B.A ; Vettorazzi, Jean F ; Ferreira, Mônica S ; Rentz, Thiago ; Catharino, Rodrigo R ; Oliveira, Helena C.F</creatorcontrib><description>Highlights • Hypercholesterolemic mice have reduced insulin secretion. • We hypothesized that pravastatin treatment improves insulin secretion. • Pravastatin chronic treatment impaired glucose stimulated insulin secretion. • Pravastatin also decreased the expression of exocytotic SNARE proteins. • Pravastatin induced apoptosis signaling and death rates in pancreatic islets.</description><identifier>ISSN: 0300-483X</identifier><identifier>EISSN: 1879-3185</identifier><identifier>DOI: 10.1016/j.tox.2015.12.007</identifier><identifier>PMID: 26875785</identifier><language>eng</language><publisher>Ireland: Elsevier Ireland Ltd</publisher><subject>Animals ; Apoptosis ; Cholesterol ; Diabetes ; Drug Administration Schedule ; Emergency ; Exocytosis - drug effects ; Exocytosis - physiology ; Female ; Glucose ; Hydroxymethylglutaryl-CoA Reductase Inhibitors - toxicity ; Hypercholesterolemia - genetics ; Hypercholesterolemia - metabolism ; Hypercholesterolemia - pathology ; Insulin ; Insulin - metabolism ; Insulin secretion ; Insulin-Secreting Cells - drug effects ; Insulin-Secreting Cells - metabolism ; Insulin-Secreting Cells - pathology ; LDL receptor ; Markers ; Mice ; Mice, Inbred C57BL ; Mice, Knockout ; Pravastatin - toxicity ; Proteins ; Receptors, LDL - deficiency ; Receptors, LDL - genetics ; Secretions ; SNARE proteins ; Statins</subject><ispartof>Toxicology (Amsterdam), 2016-02, Vol.344, p.42-52</ispartof><rights>Elsevier Ireland Ltd</rights><rights>2016 Elsevier Ireland Ltd</rights><rights>Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c474t-bef2915995bd1e833f84429f3d8f39a57ed4e48064261560ba04b5a1f88845553</citedby><cites>FETCH-LOGICAL-c474t-bef2915995bd1e833f84429f3d8f39a57ed4e48064261560ba04b5a1f88845553</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0300483X15300627$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26875785$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Lorza-Gil, Estela</creatorcontrib><creatorcontrib>Salerno, Alessandro G</creatorcontrib><creatorcontrib>Wanschel, Amarylis C.B.A</creatorcontrib><creatorcontrib>Vettorazzi, Jean F</creatorcontrib><creatorcontrib>Ferreira, Mônica S</creatorcontrib><creatorcontrib>Rentz, Thiago</creatorcontrib><creatorcontrib>Catharino, Rodrigo R</creatorcontrib><creatorcontrib>Oliveira, Helena C.F</creatorcontrib><title>Chronic use of pravastatin reduces insulin exocytosis and increases β-cell death in hypercholesterolemic mice</title><title>Toxicology (Amsterdam)</title><addtitle>Toxicology</addtitle><description>Highlights • Hypercholesterolemic mice have reduced insulin secretion. • We hypothesized that pravastatin treatment improves insulin secretion. • Pravastatin chronic treatment impaired glucose stimulated insulin secretion. • Pravastatin also decreased the expression of exocytotic SNARE proteins. • Pravastatin induced apoptosis signaling and death rates in pancreatic islets.</description><subject>Animals</subject><subject>Apoptosis</subject><subject>Cholesterol</subject><subject>Diabetes</subject><subject>Drug Administration Schedule</subject><subject>Emergency</subject><subject>Exocytosis - drug effects</subject><subject>Exocytosis - physiology</subject><subject>Female</subject><subject>Glucose</subject><subject>Hydroxymethylglutaryl-CoA Reductase Inhibitors - toxicity</subject><subject>Hypercholesterolemia - genetics</subject><subject>Hypercholesterolemia - metabolism</subject><subject>Hypercholesterolemia - pathology</subject><subject>Insulin</subject><subject>Insulin - metabolism</subject><subject>Insulin secretion</subject><subject>Insulin-Secreting Cells - drug effects</subject><subject>Insulin-Secreting Cells - metabolism</subject><subject>Insulin-Secreting Cells - pathology</subject><subject>LDL receptor</subject><subject>Markers</subject><subject>Mice</subject><subject>Mice, Inbred C57BL</subject><subject>Mice, Knockout</subject><subject>Pravastatin - toxicity</subject><subject>Proteins</subject><subject>Receptors, LDL - deficiency</subject><subject>Receptors, LDL - genetics</subject><subject>Secretions</subject><subject>SNARE proteins</subject><subject>Statins</subject><issn>0300-483X</issn><issn>1879-3185</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkkuO1DAQhi0EYpqBA7BBWbJJKL8SR0hIqMVLGokFILGzHKeidpOOGzsZTV-Lg3AmKvTAggWwsMou_fW7VF8x9phDxYHXz_bVHG8qAVxXXFQAzR224aZpS8mNvss2IAFKZeTnC_Yg5z0ACKnq--xC1KbRjdEbNm13KU7BF0vGIg7FMblrl2c3h6lI2C8ecxGmvIz0xpvoT3PMIRdu6intE7pMgu_fSo_jWPTo5h3li93piMnv4oh5xkThQD_QwYfs3uDGjI9u4yX79PrVx-3b8ur9m3fbl1elV42ayw4H0XLdtrrrORopB6OUaAfZm0G2TjfYK1QGaiVqrmvoHKhOOz4YY5TWWl6yp2ffY4pfF-rCHkJee3QTxiVbbsBAo6US_5bSnIQGzeV_SBtJtvDTlZ-lPsWcEw72mMLBpZPlYFd4dm8Jnl3hWS4swaOaJ7f2S3fA_nfFL1okeH4WII3uOmCy2QecPPYhoZ9tH8Nf7V_8Ue2JavBu_IInzPu4pImYWG4zFdgP6_asy8M1XWrRyB8ZcMAZ</recordid><startdate>20160217</startdate><enddate>20160217</enddate><creator>Lorza-Gil, Estela</creator><creator>Salerno, Alessandro G</creator><creator>Wanschel, Amarylis C.B.A</creator><creator>Vettorazzi, Jean F</creator><creator>Ferreira, Mônica S</creator><creator>Rentz, Thiago</creator><creator>Catharino, Rodrigo R</creator><creator>Oliveira, Helena C.F</creator><general>Elsevier Ireland Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7ST</scope><scope>7U7</scope><scope>C1K</scope><scope>SOI</scope><scope>8FD</scope><scope>FR3</scope><scope>KR7</scope></search><sort><creationdate>20160217</creationdate><title>Chronic use of pravastatin reduces insulin exocytosis and increases β-cell death in hypercholesterolemic mice</title><author>Lorza-Gil, Estela ; Salerno, Alessandro G ; Wanschel, Amarylis C.B.A ; Vettorazzi, Jean F ; Ferreira, Mônica S ; Rentz, Thiago ; Catharino, Rodrigo R ; Oliveira, Helena C.F</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c474t-bef2915995bd1e833f84429f3d8f39a57ed4e48064261560ba04b5a1f88845553</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Animals</topic><topic>Apoptosis</topic><topic>Cholesterol</topic><topic>Diabetes</topic><topic>Drug Administration Schedule</topic><topic>Emergency</topic><topic>Exocytosis - drug effects</topic><topic>Exocytosis - physiology</topic><topic>Female</topic><topic>Glucose</topic><topic>Hydroxymethylglutaryl-CoA Reductase Inhibitors - toxicity</topic><topic>Hypercholesterolemia - genetics</topic><topic>Hypercholesterolemia - metabolism</topic><topic>Hypercholesterolemia - pathology</topic><topic>Insulin</topic><topic>Insulin - metabolism</topic><topic>Insulin secretion</topic><topic>Insulin-Secreting Cells - drug effects</topic><topic>Insulin-Secreting Cells - metabolism</topic><topic>Insulin-Secreting Cells - pathology</topic><topic>LDL receptor</topic><topic>Markers</topic><topic>Mice</topic><topic>Mice, Inbred C57BL</topic><topic>Mice, Knockout</topic><topic>Pravastatin - toxicity</topic><topic>Proteins</topic><topic>Receptors, LDL - deficiency</topic><topic>Receptors, LDL - genetics</topic><topic>Secretions</topic><topic>SNARE proteins</topic><topic>Statins</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lorza-Gil, Estela</creatorcontrib><creatorcontrib>Salerno, Alessandro G</creatorcontrib><creatorcontrib>Wanschel, Amarylis C.B.A</creatorcontrib><creatorcontrib>Vettorazzi, Jean F</creatorcontrib><creatorcontrib>Ferreira, Mônica S</creatorcontrib><creatorcontrib>Rentz, Thiago</creatorcontrib><creatorcontrib>Catharino, Rodrigo R</creatorcontrib><creatorcontrib>Oliveira, Helena C.F</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Environment Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Environment Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Civil Engineering Abstracts</collection><jtitle>Toxicology (Amsterdam)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lorza-Gil, Estela</au><au>Salerno, Alessandro G</au><au>Wanschel, Amarylis C.B.A</au><au>Vettorazzi, Jean F</au><au>Ferreira, Mônica S</au><au>Rentz, Thiago</au><au>Catharino, Rodrigo R</au><au>Oliveira, Helena C.F</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Chronic use of pravastatin reduces insulin exocytosis and increases β-cell death in hypercholesterolemic mice</atitle><jtitle>Toxicology (Amsterdam)</jtitle><addtitle>Toxicology</addtitle><date>2016-02-17</date><risdate>2016</risdate><volume>344</volume><spage>42</spage><epage>52</epage><pages>42-52</pages><issn>0300-483X</issn><eissn>1879-3185</eissn><abstract>Highlights • Hypercholesterolemic mice have reduced insulin secretion. • We hypothesized that pravastatin treatment improves insulin secretion. • Pravastatin chronic treatment impaired glucose stimulated insulin secretion. • Pravastatin also decreased the expression of exocytotic SNARE proteins. • Pravastatin induced apoptosis signaling and death rates in pancreatic islets.</abstract><cop>Ireland</cop><pub>Elsevier Ireland Ltd</pub><pmid>26875785</pmid><doi>10.1016/j.tox.2015.12.007</doi><tpages>11</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0300-483X |
ispartof | Toxicology (Amsterdam), 2016-02, Vol.344, p.42-52 |
issn | 0300-483X 1879-3185 |
language | eng |
recordid | cdi_proquest_miscellaneous_1808075342 |
source | MEDLINE; Elsevier ScienceDirect Journals |
subjects | Animals Apoptosis Cholesterol Diabetes Drug Administration Schedule Emergency Exocytosis - drug effects Exocytosis - physiology Female Glucose Hydroxymethylglutaryl-CoA Reductase Inhibitors - toxicity Hypercholesterolemia - genetics Hypercholesterolemia - metabolism Hypercholesterolemia - pathology Insulin Insulin - metabolism Insulin secretion Insulin-Secreting Cells - drug effects Insulin-Secreting Cells - metabolism Insulin-Secreting Cells - pathology LDL receptor Markers Mice Mice, Inbred C57BL Mice, Knockout Pravastatin - toxicity Proteins Receptors, LDL - deficiency Receptors, LDL - genetics Secretions SNARE proteins Statins |
title | Chronic use of pravastatin reduces insulin exocytosis and increases β-cell death in hypercholesterolemic mice |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-01T16%3A23%3A11IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Chronic%20use%20of%20pravastatin%20reduces%20insulin%20exocytosis%20and%20increases%20%CE%B2-cell%20death%20in%20hypercholesterolemic%20mice&rft.jtitle=Toxicology%20(Amsterdam)&rft.au=Lorza-Gil,%20Estela&rft.date=2016-02-17&rft.volume=344&rft.spage=42&rft.epage=52&rft.pages=42-52&rft.issn=0300-483X&rft.eissn=1879-3185&rft_id=info:doi/10.1016/j.tox.2015.12.007&rft_dat=%3Cproquest_cross%3E1773807042%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1773807042&rft_id=info:pmid/26875785&rft_els_id=1_s2_0_S0300483X15300627&rfr_iscdi=true |